PACS CEO Jason Hulse Murray Sells $403K of Stock

Jason Hulse Murray, Co-Founder, CEO & Chairman of PACS Group, Inc. (NYSE:PACS), sold 8,462 shares of the company on October 16, 2026. According to a Form 4 filing with the Securities and Exchange Commission, the shares were sold at a price of $47.61 each, bringing the total value of the transaction to $402,875.82.

Inside Jason Hulse Murray's PACS Trade

The sale involved 8,462 shares executed on October 16, 2026, at $47.61 per share. Following this transaction, the CEO's holdings adjusted accordingly. This pre-planned transaction was executed under a Rule 10b5-1 trading plan, which allows insiders to set up a predetermined schedule to buy or sell stock. On the day of the trade, the company's stock closed at $46.91.

Other Institutional Activity in PACS Group

Large funds continue to adjust their positions in the healthcare operator. Cohen & Steers Inc. reduced its holdings by 780,054 shares, ending with 8,343,381 shares worth about $391,388,001. Crewe Advisors LLC grew its holdings by 553,034 shares, ending with 3,307,188 shares worth about $155,140,188 for a 20.1% increase. American Century Companies Inc grew its holdings by 1,298,580 shares, ending with 3,108,196 shares worth about $145,805,473 for a 71.8% increase. Ameriprise Financial, Inc. grew its holdings by 873,697 shares, ending with 1,995,116 shares worth about $93,590,891 for a 77.9% increase. Alyeska Investment Group, L.p. reduced its holdings by 1,463,403 shares, ending with 1,539,065 shares worth about $72,197,538 for a 48.7% decrease.

PACS Group, Inc. Stock Down 2.1%

The stock recently traded around $46.76, down about 0.3% from its event-day close of $46.91 on October 16, 2026. Shares sit below the 52-week peak of $49.49 while maintaining distance above the 200-day moving average of $39.31.

Recent Earnings

PACS Group reported trailing-twelve-month revenue of $5.55 billion and earnings of $1.71 per share. The healthcare provider posted a net profit margin of 4.8% alongside a return on equity of 27.9%. The next earnings update is scheduled for November 9, 2026.

Dividend

The company maintains a payout ratio of 0.0% and offers a dividend yield of 0.0%, reflecting that it does not currently distribute a regular dividend to shareholders.

Insider Buying and Selling at PACS Group, Inc.

Insider activity has been active over recent months. Director Mark Hancock sold 300,000 shares valued at $13,044,882 on September 15, 2026. President Joshua Jergensen sold 40,000 shares worth $1,725,133 on September 16, 2026. CEO Jason Hulse Murray previously sold 83,308 shares for $3,499,286 on October 5, 2026, followed by another sale of 36,692 shares worth $1,580,701 on October 7, 2026.

Analysts Set New Price Targets

Wall Street firms maintain an optimistic outlook on the stock. UBS maintains a Buy rating with a $60.0 target set on August 6, 2026. RBC Capital maintains an Outperform rating with a $57.0 target on August 6, 2026. Truist Securities maintains a Buy rating with a $62.0 target on August 6, 2026. Oppenheimer maintains an Outperform rating with a $57.0 target on August 10, 2026. JP Morgan maintains an Overweight rating with a $58.0 target on September 4, 2026. The consensus recommendation stands at strong_buy across 6 analyst opinions.

About PACS Group, Inc.

Headquartered in Salt Lake City, Utah, PACS Group operates skilled nursing facilities, assisted living centers, and senior care properties across the United States. The healthcare real estate operator manages extensive care facilities for aging populations, focusing on property acquisitions, leasing, and resident care services since its founding in 2013.

Bottom Line

Investors will look ahead to the company's upcoming earnings release on November 9, 2026, for further updates on financial performance. Insider transactions under Rule 10b5-1 plans provide scheduled liquidity for executives but remain a standard item to monitor alongside institutional filing trends.